|
1
|
Marosi C, Hassler M, Roessler K, Reni M,
Sant M, Mazza E and Vecht C: Meningioma. Crit Rev Oncol Hematol.
67:153–171. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ogasawara C, Philbrick BD and Adamson DC:
Meningioma: A review of epidemiology, pathology, diagnosis,
treatment, and future directions. Biomedicines.
9(319)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vuong HG, Ngo TNM and Dunn IF: Incidence,
risk factors, and prognosis of meningiomas with distant metastases
at presentation. Neurooncol Adv. 3(vdab084)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yamamoto J, Takahashi M, Idei M, Nakano Y,
Soejima Y, Akiba D, Kitagawa T, Ueta K, Miyaoka R and Nishizawa S:
Clinical features and surgical management of intracranial
meningiomas in the elderly. Oncol Lett. 14:909–917. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang CC, Tsai CC, Chen SJ, Chiang MF, Lin
JF, Hu CK, Chan YK, Lin HY and Cheng SY: Factors associated with
recurrence of intracranial meningiomas after surgical resection: A
retrospective single-center study. Int Journal of Gerontol.
12:57–61. 2018.
|
|
7
|
Hwang WL, Marciscano AE, Niemierko A, Kim
DW, Stemmer-Rachamimov AO, Curry WT, Barker FG II, Martuza RL,
Loeffler JS, Oh KS, et al: Imaging and extent of surgical resection
predict risk of meningioma recurrence better than WHO
histopathological grade. Neuro Oncol. 18:863–872. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Varki A: Biological roles of glycans.
Glycobiology. 27:3–49. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dobie C and Skropeta D: Insights into the
role of sialylation in cancer progression and metastasis. Br J
Cancer. 124:76–90. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhou X, Yang G and Guan F: Biological
functions and analytical strategies of sialic acids in tumor.
Cells. 9(273)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Christie DR, Shaikh FM, Lucas JA IV, Lucas
JA III and Bellis SL: ST6Gal-I expression in ovarian cancer cells
promotes an invasive phenotype by altering integrin glycosylation
and function. J Ovarian Res. 1(3)2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang X, Dou P, Akhtar ML, Liu F, Hu X,
Yang L, Yang D, Zhang X, Li Y, Qiao S, et al: NEU4 inhibits
motility of HCC cells by cleaving sialic acids on CD44. Oncogene.
40:5427–5440. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cazet A, Julien S, Bobowski M,
Krzewinski-Recchi MA, Harduin-Lepers A, Groux-Degroote S and
Delannoy P: Consequences of the expression of sialylated antigens
in breast cancer. Carbohydr Res. 345:1377–1383. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Talabnin C, Trasaktaweesakul T,
Jaturutthaweechot P, Asavaritikrai P, Kongnawakun D, Silsirivanit
A, Araki N and Talabnin K: Altered O-linked glycosylation in benign
and malignant meningiomas. PeerJ. 12(e16785)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Naradun N, Talabnin K, Ayuttha KIN and
Talabnin C: Piperlongumine and bortezomib synergically inhibit
cholangiocarcinoma via ER stress-induced cell death. Naunyn
Schmiedebergs Arch Pharmacol. 396:109–120. 2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Macauley MS, Crocker PR and Paulson JC:
Siglec-mediated regulation of immune cell function in disease. Nat
Rev Immunol. 14:653–666. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Swindall AF and Bellis SL: Sialylation of
the Fas death receptor by ST6Gal-I provides protection against
Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem.
286:22982–22990. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chiodelli P, Urbinati C, Paiardi G, Monti
E and Rusnati M: Sialic acid as a target for the development of
novel antiangiogenic strategies. Future Med Chem. 10:2835–2854.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zou X, Lu J, Deng Y, Liu Q, Yan X, Cui Y,
Xiao X, Fang M, Yang F, Sawaki H, et al: ST6GAL1 inhibits
metastasis of hepatocellular carcinoma via modulating sialylation
of MCAM on cell surface. Oncogene. 42:516–529. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Park DD, Xu G, Park SS, Haigh NE, Phoomak
C, Wongkham S, Maverakis E and Lebrilla CB: Combined analysis of
secreted proteins and glycosylation identifies prognostic features
in cholangiocarcinoma. J Cell Physiol. 239(e31147)2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Al Saoud R, Hamrouni A, Idris A, Mousa WK
and Abu Izneid T: Recent advances in the development of
sialyltransferase inhibitors to control cancer metastasis: A
comprehensive review. Biomed Pharmacother.
165(115091)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cui HX, Wang H, Wang Y, Song J, Tian H,
Xia C and Shen Y: ST3Gal III modulates breast cancer cell adhesion
and invasion by altering the expression of invasion-related
molecules. Oncol Rep. 36:3317–3324. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lu J, Isaji T, Im S, Fukuda T, Hashii N,
Takakura D, Kawasaki N and Gu J: β-Galactoside α2,
6-sialyltranferase 1 promotes transforming growth factor-β-mediated
epithelial-mesenchymal transition. J Biol Chem. 289:34627–34641.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou L, Zhang S, Zou X, Lu J, Yang X, Xu
Z, Shan A, Jia W, Liu F, Yan X, et al: The β-galactoside
α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer
metastasis by stabilizing intercellular adhesion molecule-1 via
sialylation. Cancer Manag Res. 11:6185–6199. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jung YR, Park JJ, Jin YB, Cao YJ, Park MJ,
Kim EJ and Lee M: Silencing of ST6Gal I enhances colorectal cancer
metastasis by downregulating KAI1 via exosome-mediated exportation
and thereby rescues integrin signaling. Carcinogenesis.
37:1089–1097. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wick W, Platten M and Weller M: Glioma
cell invasion: Regulation of metalloproteinase activity by
TGF-beta. J Neurooncol. 53:177–185. 2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shibue T, Brooks MW and Weinberg RA: An
integrin-linked machinery of cytoskeletal regulation that enables
experimental tumor initiation and metastatic colonization. Cancer
Cell. 24:481–498. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Augoff K, Hryniewicz-Jankowska A, Tabola R
and Stach K: MMP9: A tough target for targeted therapy for cancer.
Cancers (Basel). 14(1847)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hou S, Wang J, Li W, Hao X and Hang Q:
Roles of integrins in gastrointestinal cancer metastasis. Front Mol
Biosci. 8(708779)2021.PubMed/NCBI View Article : Google Scholar
|
